We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+25.51%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
10 Year Est. Return
AUM
$135M
AUM Growth
-$22.4M
Cap. Flow
-$46.8M
Cap. Flow %
-34.82%
Top 10 Hldgs %
38.49%
Holding
350
New
112
Increased
40
Reduced
54
Closed
93

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$3.85M
2
AMAT icon
Applied Materials
AMAT
+$3.56M
3
LRCX icon
Lam Research
LRCX
+$3.54M
4
BIIB icon
Biogen
BIIB
+$3.49M
5
FISV
Fiserv Inc
FISV
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.17%
2 Technology 24.33%
3 Communication Services 15.05%
4 Consumer Staples 8.01%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THO icon
51
Thor Industries
THO
$4.03B
$426K 0.32%
+4,003
New +$313K
ACLS icon
52
Axcelis
ACLS
$4.03B
$398K 0.3%
14,274
-639
-4% -$15.6K
WST icon
53
West Pharmaceutical
WST
$24.5B
$381K 0.28%
1,675
-2,533
-60% -$498K
CENTA icon
54
Central Garden & Pet Co Class A
CENTA
$2.39B
$380K 0.28%
+14,040
New +$352K
VGSH icon
55
Vanguard Short-Term Treasury ETF
VGSH
$29.2B
$377K 0.28%
6,061
-9,207
-60% -$573K
MRTN icon
56
Marten Transport
MRTN
$1.22B
$375K 0.28%
+22,349
New +$351K
AON icon
57
Aon
AON
$75.9B
$372K 0.28%
1,932
-6,507
-77% -$1.21M
WERN icon
58
Werner Enterprises
WERN
$2.23B
$361K 0.27%
8,295
+2,640
+47% +$109K
KNX icon
59
Knight Transportation
KNX
$11.1B
$360K 0.27%
+8,623
New +$329K
RGEN icon
60
Repligen
RGEN
$8.3B
$352K 0.26%
+2,847
New +$335K
STMP
61
DELISTED
Stamps.com, Inc.
STMP
$344K 0.26%
+1,870
New +$320K
TYL icon
62
Tyler Technologies
TYL
$12.5B
$337K 0.25%
971
-950
-49% -$319K
CTLT
63
DELISTED
CATALENT, INC.
CTLT
$335K 0.25%
+4,576
New +$311K
BIO icon
64
Bio-Rad Laboratories Class A
BIO
$8.96B
$333K 0.25%
+737
New +$325K
REGI
65
DELISTED
Renewable Energy Group, Inc.
REGI
$329K 0.24%
+13,293
New +$337K
LBRDK icon
66
Liberty Broadband Class C
LBRDK
$4.86B
$313K 0.23%
2,522
-1,320
-34% -$166K
CORT icon
67
Corcept Therapeutics
CORT
$12.2B
$296K 0.22%
+17,606
New +$247K
SPWH icon
68
Sportsman's Warehouse
SPWH
$44.9M
$243K 0.18%
+17,066
New +$161K
CLW icon
69
Clearwater Paper
CLW
$359M
$227K 0.17%
+6,294
New +$175K
LOGI icon
70
Logitech
LOGI
$15.1B
$193K 0.14%
+2,957
New +$158K
DEA
71
Easterly Government Properties
DEA
$1.17B
$181K 0.13%
3,134
-314
-9% -$19.9K
PBH icon
72
Prestige Consumer Healthcare
PBH
$2.46B
$181K 0.13%
+4,812
New +$192K
NPTN
73
DELISTED
NEOPHOTONICS CORP
NPTN
$93K 0.07%
+10,455
New +$90.1K
SYNH
74
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$86K 0.06%
1,483
-1,696
-53% -$91.2K
QQQ icon
75
Invesco QQQ Trust
QQQ
$469B
$13K 0.01%
53

Similar funds

USA Financial Formulas's Q2 2020 Portfolio in Review

As of Q2 2020, USA Financial Formulas held 350 positions worth $135M, down 14% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

USA Financial Formulas withdrew a net $46.8M in Q2 2020, closing 93 positions and reducing 54 holdings. Its most notable exit was Gilead Sciences, an estimated $3.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 15% a quarter earlier, followed by Technology and Communication Services.

Against the trend, USA Financial Formulas opened a new position in Johnson & Johnson worth $4.23M.

  • USA Financial Formulas's largest Q2 2020 buy was Johnson & Johnson: 30,087 shares worth $4.23M.
  • USA Financial Formulas added most to DexCom in Q2 2020, an estimated $3M increase.
  • USA Financial Formulas's biggest Q2 2020 reduction was Ansys, cutting an estimated $3.85M.
  • USA Financial Formulas fully exited Gilead Sciences in Q2 2020, selling an estimated $3.34M.
  • USA Financial Formulas's ten largest holdings make up 38% of its $135M portfolio in Q2 2020.
  • USA Financial Formulas opened 112 new positions and closed 93 in Q2 2020.
  • USA Financial Formulas's portfolio value fell 14% quarter-over-quarter to $135M.

Based on USA Financial Formulas's 13F filing for Q2 2020, filed 11 Aug 2020.